Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on November 5, 2015. The filing reports the issuance of a press release regarding financial results for the fiscal quarter ended September 30, 2015.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves only as a notification that the results for the quarter ended September 30, 2015, have been announced.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer regarding forward-looking statements. Management notes that statements expressing intentions, beliefs, expectations, or predictions are based on current assumptions and are not guarantees. Actual results may differ materially due to risks and uncertainties discussed in the Company's Annual Report on Form 10-K. The Company undertakes no obligation to update these statements.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., as the input metadata incorrectly listed Sonoma Pharmaceuticals, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are not present in the 8-K body text.
- Confirm the fiscal quarter end date is September 30, 2015.
- Check the most recent Form 10-K for detailed risk factors referenced in the forward-looking statement disclaimer.